24 related articles for article (PubMed ID: 10724008)
1. Anti-Insect Properties of
Nicoletti R; Andolfi A; Becchimanzi A; Salvatore MM
Microorganisms; 2023 May; 11(5):. PubMed ID: 37317276
[TBL] [Abstract][Full Text] [Related]
2. Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer's Diseases Pathways.
Nguyen TH; Wang SL; Nguyen VB
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111337
[TBL] [Abstract][Full Text] [Related]
3. New azaphilones from Aspergillus neoglaber.
Isbrandt T; Frisvad JC; Madsen A; Larsen TO
AMB Express; 2020 Aug; 10(1):145. PubMed ID: 32804338
[TBL] [Abstract][Full Text] [Related]
4. A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.
Al-Rashid ZF; Hsung RP
Bioorg Med Chem Lett; 2015 Nov; 25(21):4848-4853. PubMed ID: 26159481
[TBL] [Abstract][Full Text] [Related]
5. Territrem and butyrolactone derivatives from a marine-derived fungus Aspergillus terreus.
Nong XH; Wang YF; Zhang XY; Zhou MP; Xu XY; Qi SH
Mar Drugs; 2014 Dec; 12(12):6113-24. PubMed ID: 25522319
[TBL] [Abstract][Full Text] [Related]
6. (+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.
Al-Rashid ZF; Hsung RP
Bioorg Med Chem Lett; 2011 May; 21(9):2687-91. PubMed ID: 21216144
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
8. Arisugacins A and B, novel and selective acetylcholinesterase inhibitors from Penicillium sp. FO-4259. I. Screening, taxonomy, fermentation, isolation and biological activity.
Kuno F; Otoguro K; Shiomi K; Iwai Y; Omura S
J Antibiot (Tokyo); 1996 Aug; 49(8):742-7. PubMed ID: 8823504
[TBL] [Abstract][Full Text] [Related]
9. Arisugacins, selective acetylcholinesterase inhibitors of microbial origin.
Otoguro K; Kuno F; Omura S
Pharmacol Ther; 1997; 76(1-3):45-54. PubMed ID: 9535168
[TBL] [Abstract][Full Text] [Related]
10. Arisugacins A and B, novel and selective acetylcholinesterase inhibitors from Penicillium sp. FO-4259. II. Structure elucidation.
Kuno F; Shiomi K; Otoguro K; Sunazuka T; Omura S
J Antibiot (Tokyo); 1996 Aug; 49(8):748-51. PubMed ID: 8823505
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterase Inhibitory Arisugacins L-Q from a
Dai W; Sandoval IT; Cai S; Smith KA; Delacruz RGC; Boyd KA; Mills JJ; Jones DA; Cichewicz RH
J Nat Prod; 2019 Sep; 82(9):2627-2637. PubMed ID: 31433188
[TBL] [Abstract][Full Text] [Related]
12. Arisugacin, a novel and selective inhibitor of acetylcholinesterase from Penicillium sp. FO-4259.
Omura S; Kuno F; Otoguro K; Sunazuka T; Shiomi K; Masuma R; Iwai Y
J Antibiot (Tokyo); 1995 Jul; 48(7):745-6. PubMed ID: 7649881
[No Abstract] [Full Text] [Related]
13. Arisugacins C and D, novel acetylcholinesterase inhibitors and their related novel metabolites produced by Penicilium sp. FO-4259-11.
Otoguro K; Shiomi K; Yamaguchi Y; Arai N; Sunazuka T; Masuma R; Iwai Y; Omura S
J Antibiot (Tokyo); 2000 Jan; 53(1):50-7. PubMed ID: 10724008
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
